Mednax Inc $ 15.81 -0.97 (-5.78%)
On watch
Volume:
258,318
Avg Vol (1m):
713,981
Market Cap $:
1.35 Bil
Enterprise Value $:
2.95 Bil
P/E (TTM):
0.00
P/B:
1.64
Financial Strength | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.12 | ||
| Equity-to-Asset | 0.24 | ||
| Debt-to-Equity | 2.2 | ||
| Debt-to-EBITDA | -1.58 | ||
| Interest Coverage | 2.72 | ||
| Piotroski F-Score | 3 | ||
| Altman Z-Score | 0.1 | ||
| Beneish M-Score | -3.89 | ||
| WACC vs ROIC | |||
Profitability Rank | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 9.81 | ||
| Net Margin % | -61.53 | ||
| ROE % | -120.85 | ||
| ROA % | -44.48 | ||
| ROC (Joel Greenblatt) % | -309.45 | ||
| 3-Year Revenue Growth Rate | 7.2 |
Valuation Rank | 10/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Forward PE Ratio | 7.51 | ||
| PB Ratio | 1.64 | ||
| PS Ratio | 0.41 | ||
| Price-to-Free-Cash-Flow | 4.52 | ||
| Price-to-Operating-Cash-Flow | 3.98 | ||
| EV-to-EBIT | -2.39 | ||
| EV-to-EBITDA | -2.55 | ||
| EV-to-Revenue | 0.93 | ||
| Shiller PE Ratio | 147.76 | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.79 | ||
| Days Sales Outstanding | 40.07 | ||
| Days Payable | 7.49 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 3.5 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 0.32 | ||
| Price-to-Median-PS-Value | 0.2 | ||
| Earnings Yield (Greenblatt) % | -41.96 | ||
| Forward Rate of Return (Yacktman) % | 22.96 |